Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Publications
  • Media
  • Contact

Geir Bjørklund, MD

Founder, Björklund Pharma AS

Björklund Pharma AS
Toften 24
8610 Mo i Rana, Norway
Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Geir Bjørklund, MD, is a medical researcher and scientific advisor with a focus on nutritional and environmental medicine. His work examines how trace elements, micronutrients, and environmental exposures affect human health, with emphasis on chronic and neurodevelopmental disorders.

He is the founder and president of the Council for Nutritional and Environmental Medicine (CONEM), an international network of clinicians and researchers in nutrition, toxicology, and environmental health. He has authored or co-authored more than 400 scientific publications and book chapters across nutritional biochemistry, toxicology, neurodevelopment, and public health.

Bjørklund holds editorial roles in several peer-reviewed journals, including service as deputy chief editor of Metabolic Brain Disease, advisory editor of Archives of Toxicology, and section editor for Current Medicinal Chemistry and Current Pharmaceutical Design. He is a member of the World Association of Medical Editors (WAME), has contributed to expert reports for the Norwegian Board of Health on dental restorative materials, has served as a reviewer for the Swiss National Science Foundation and the Israel Science Foundation, and is a board member of Tandhälsoförbundets Forskningsstiftelse (Dental Health Association Research Foundation) in Sweden. He has received honorary professorships at medical universities in Kazakhstan and Uzbekistan for contributions to environmental and clinical research and scientific communication.

At Björklund Pharma AS, his scientific background guides the company’s focus on therapies based on biofactors and natural compounds and supports a structured, transparent approach to documentation and collaboration with academic and clinical partners.

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS